BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862
1012 results:

  • 1. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian cancer.
    Flores-Colón M; Rivera-Serrano M; Reyes-Burgos VG; Rolón JG; Pérez-Santiago J; Marcos-Martínez MJ; Valiyeva F; Vivas-Mejía PE
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612604
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Combined deletion of MEN1, ATRX and pten triggers development of high-grade pancreatic neuroendocrine tumors in mice.
    Fuentes ME; Lu X; Flores NM; Hausmann S; Mazur PK
    Sci Rep; 2024 Apr; 14(1):8510. PubMed ID: 38609433
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MATN2 overexpression suppresses tumor growth in ovarian cancer via pten/PI3K/AKT pathway.
    Liu J; Zhang J; Zhang Y; Yang B; Liu H; Chen Y
    Funct Integr Genomics; 2024 Apr; 24(2):71. PubMed ID: 38568332
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diosgenin inhibits proliferation and migration of ovarian cancer cells and induce apoptosis via upregulation of pten.
    Fang F; Zhang X; Fang Y
    Chem Biol Drug Des; 2024 Mar; 103(3):e14459. PubMed ID: 38538058
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Complexity of the Genetic Background of Oncogenesis in Ovarian cancer-Genetic Instability and Clinical Implications.
    Murawski M; Jagodziński A; Bielawska-Pohl A; Klimczak A
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391958
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. β-Sitosterol targets ASS1 for Nrf2 ubiquitin-dependent degradation, inducing ROS-mediated apoptosis via the pten/PI3K/AKT signaling pathway in ovarian cancer.
    Wang H; Liu J; Zhang Z; Peng J; Wang Z; Yang L; Wang X; Hu S; Hong L
    Free Radic Biol Med; 2024 Mar; 214():137-157. PubMed ID: 38364944
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with
    Oh Y; Park JH; Djunadi TA; Shah Z; Chung LI; Chae YK
    Front Endocrinol (Lausanne); 2024; 15():1304188. PubMed ID: 38356955
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma.
    Chen Y; Lei Y; Li J; Wang X; Li G
    Int Immunopharmacol; 2024 Mar; 129():111590. PubMed ID: 38316083
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling.
    Sun M; Zhao M; Li R; Zhang Y; Shi X; Ding C; Ma C; Lu J; Yue X
    Cell Death Dis; 2024 Jan; 15(1):87. PubMed ID: 38272883
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PW06 suppresses cancer cell metastasis in human pancreatic carcinoma MIA PaCa-2 cells via the inhibitions of p-Akt/mTOR/NF-κB and MMP2/MMP9 signaling pathways in vitro.
    Huang YP; Yeh CA; Ma YS; Chen PY; Lai KC; Lien JC; Hsieh WT
    Environ Toxicol; 2024 May; 39(5):2768-2781. PubMed ID: 38264921
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Utilizing pten immunohistochemistry as a screening test for Cowden syndrome.
    Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
    Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transcriptomic Analysis of the Aged Nulliparous Mouse Ovary Suggests a Stress State That Promotes Pro-Inflammatory Lipid Signaling and Epithelial Cell Enrichment.
    Chacón C; Mounieres C; Ampuero S; Urzúa U
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203684
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic predisposition to differentiated thyroid cancer in the Polish population.
    Borowczyk M; Sypniewski M; Szyda J; Braszka M; Ziemnicka K; Ruchała M; Oszywa M; Król ZJ; Dobosz P
    Pol Arch Intern Med; 2024 Mar; 134(3):. PubMed ID: 38165228
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells.
    Ravindran F; Mhatre A; Koroth J; Narayan S; Choudhary B
    Life Sci; 2023 Dec; 334():122224. PubMed ID: 38084671
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian cancer.
    Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
    Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long non-coding RNA EGOT is associated with
    Wang M; Wei Z; Wang S; Feng W; Shang L; Sun X
    Aging (Albany NY); 2023 Nov; 15(22):13542-13557. PubMed ID: 38006396
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the pten/AKT and SOCS6/STAT3 pathways.
    Sun L; Ke M; Yin M; Zeng Y; Ji Y; Hu Y; Fu S; Zhang C
    Cancer Sci; 2024 Jan; 115(1):155-169. PubMed ID: 37972389
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PINK1-pten axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.
    Zheng F; Zhong J; Chen K; Shi Y; Wang F; Wang S; Tang S; Yuan X; Shen Z; Tang S; Xia D; Wu Y; Lu W
    J Exp Clin Cancer Res; 2023 Nov; 42(1):295. PubMed ID: 37940999
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. USP10 suppresses ABCG2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway.
    Sun J; Xiang Q; Ding D; Yan N
    J Bioenerg Biomembr; 2023 Dec; 55(6):457-466. PubMed ID: 37919637
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Differential cell cycle checkpoint evasion by pten germline mutations associated with dichotomous phenotypes of cancer versus autism spectrum disorder.
    Hitomi M; Venegas J; Kang SC; Eng C
    Oncogene; 2023 Dec; 42(50):3698-3707. PubMed ID: 37907589
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 51.